Montana Molecular attended the annual National Institutes of Health (NIH) SBIR conference to learn more about the agency’s mission of improving human health and developing new technologies with commercial application. The NIH SBIR program offers over $700M in support for small businesses (under 500 employees) to perform innovative research in the biomedical /behavioral sciences through its SBIR and STTR programs. This year’s conference “The Changing Face of SBIR/STTR”, offered presentations from NIH program staff, representatives from SBIR companies, and other experts, including Kentucky governor Steve Beshear. The conference featured free tours of the Cardiovascular Innovation Institute (CII) at the University of Louisville and the United Parcel Service (UPS) Healthcare Logistics and Distribution Facilities.
Montana Molecular presented results from their current SBIR grant entitled “New Genetically Encoded Biosensors”, describing an innovative new platform for drug discovery and cell signaling research. All attendees were given the opportunity for one-on-one meetings with NIH SBIR program staff from the various NIH institutes, including the NIMH, NCI and NINDS. These meetings were particularly valuable to Montana Molecular because company scientists had the opportunity to talk directly with NIH program staff about the impact of their technology and their progress toward commercialization.
Program staff from the National Science Foundation (NSF) and the Department of Defense also participated in one-on-one meetings and gave presentations describing current solicitations for applications from these agencies. For companies in Montana that are interested in applying for SBIR funding to support their research and development, a good resource for more information is available through Montana Technology Innovation Partnership (MTIP) mtip.mt.gov.